Loading...

Genetic Signatures Limited

GSS.AXASX
HealthcareMedical - Diagnostics & Research
A$0.43
A$-0.01(-2.27%)

Genetic Signatures Limited (GSS.AX) Company Profile & Overview

Explore Genetic Signatures Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Genetic Signatures Limited (GSS.AX) Company Profile & Overview

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMs. Allison Rossiter

Contact Information

61 2 9870 7580
Heart Research Institute, Newtown, NSW, 2042

Company Facts

IPO DateMar 30, 2015
CountryAU
Actively Trading

Frequently Asked Questions